Hepatitis C Virus E2 Envelope Glycoprotein Core Structure
- The Scripps Research Inst., La Jolla, CA (United States)
Hepatitis C virus (HCV), a Hepacivirus, is a major cause of viral hepatitis, liver cirrhosis, and hepatocellular carcinoma. HCV envelope glycoproteins E1 and E2 mediate fusion and entry into host cells and are the primary targets of the humoral immune response. The crystal structure of the E2 core bound to broadly neutralizing antibody AR3C at 2.65 angstroms reveals a compact architecture composed of a central immunoglobulin-fold β sandwich flanked by two additional protein layers. The CD81 receptor binding site was identified by electron microscopy and site-directed mutagenesis and overlaps with the AR3C epitope. The x-ray and electron microscopy E2 structures differ markedly from predictions of an extended, three-domain, class II fusion protein fold and therefore provide valuable information for HCV drug and vaccine design.
- Research Organization:
- SLAC National Accelerator Laboratory (SLAC)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1154700
- Report Number(s):
- SLAC-REPRINT-2014-279
- Journal Information:
- Science, Journal Name: Science Journal Issue: 6162 Vol. 342; ISSN 0036-8075
- Country of Publication:
- United States
- Language:
- English
Similar Records
Structure of Hepatitis C virus envelope glycoprotein E1 antigenic site 314–324 in complex with antibody IGH526
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
Journal Article
·
Tue Jun 30 00:00:00 EDT 2015
· Journal of Molecular Biology
·
OSTI ID:1214858
Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1
Journal Article
·
Mon Oct 29 00:00:00 EDT 2012
· Proc. Natl. Acad. Sci. USA
·
OSTI ID:1046254
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines
Journal Article
·
Wed Apr 01 00:00:00 EDT 2020
· Science Advances
·
OSTI ID:1816263